研究業績:2012年
英文原著
Li YY, Yamagishi K, Yatsuya H, Tamakoshi A, Iso H. Smoking cessation and COPD mortality among Japanese men and women: The JACC Study. Prev Med 2012; 55:639-643. Imano H, Iso H, Kiyama M, Yamagishi K, Ohira T, Sato S, Noda H, Maeda K, Okada T, Tanigawa T, Kitamura A; the CIRCS Investigators. Non-fasting blood glucose and risk of incident coronary heart disease in middle-aged general population: The Circulatory Risk in Communities Study (CIRCS). Prev Med 2012; 55:603-607. Eshak ES, Iso H, Kokubo Y, Saito I, Yamagishi K, Inoue M, Tsugane S; for the JPHC Study Group. Soft drink intake in relation to incident coronary heart disease, stroke, and stroke subtypes in Japanese men and women: the Japan Public Health Centre-based (JPHC) Study Cohort I. Am J Clin Nutr 2012; 96:1390-1397. Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Lambers Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti J, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG; on behalf of the CKD Prognosis Consortium. Associations of kidney disease measure with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis of 1,024,977 individuals. Lancet 2012; 380:1662-1673. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang, L, Coresh J, de Jong PE, Astor BC; for the Chronic Kidney Disease Prognosis Consortium. Effect modification by hypertensive status of the association of chronic kidney disease measures with mortality and end-stage renal disease: meta-analysis of 1,127,656 individuals from 45 cohorts. Lancet 2012; 380:1649-1661. Folsom AR, Nambi V, Pankow JS, Tang W, Farbakhsh K, Yamagishi K, Boerwinkle E. Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2012; 224:435-439. Nagao M, Moriyama Y, Yamagishi K, Iso H, Tamakoshi A; for the JACC Study Group. Relationship of serum α- and γ-tocopherol levels to cardiovascular disease-related mortality among Japanese men and women. J Epidemiol 2012; 22:402-410. Iso H, Maruyama K, Ikehara S, Yamagishi K, Tamakoshi A. Cellular growth factors in relation to mortality from cardiovascular disease in middle-aged Japanese: the JACC Study. Atherosclerosis 2012; 224:154-160. Yamagishi K, Sato S, Kitamura A, Kiyama M, Okada T, Tanigawa T, Ohira T, Imano H, Kondo M, Okubo I, Ishikawa Y, Shimamoto T, Iso H; for the CIRCS Investigators. Cost-effectiveness and budget impact analyses of a long-term hypertension detection and control program for stroke prevention. J Hypertens 2012; 30:1874-1879. Iso H, Noda H, Ikeda A, Yamagishi K, Inoue M, Tsugane S; for the JPHC Study Group. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan Public Health Center-Based Study. J Atheroscler Thromb 2012; 8:756-766. Nagayoshi M, Tanigawa T, Yamagishi K, Sakurai S, Kitamura A, Kiyama M, Okada T, Maeda K, Ohira T, Imano H, Sato S, Iso H; for the CIRCS Investigators. Self-reported snoring frequency and incidence of cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS). J Epidemiol 22:295-301 Nagao M, Iso H, Yamagishi K, Date C, Tamakoshi A; for the JACC Study Group. Meat consumption in relation to mortality from cardiovascular disease among Japanese men and women. Eur J Clin Nutr 2012;66:687-693. Ohira T, Maruyama M, Imano H, Kitamura A, Kiyama M, Okada T, Maeda K, Yamagishi K, Noda H, Cui R, Masuda S, Kimura H, Tachikawa K, Ishikawa Y, Iso H. Risk factors for sudden cardiac death among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Hypertens 2012; 30:1137-1143. Tsujimoto T, Sairenchi T, Iso H, Irie F, Yamagishi K, Tanaka K, Muto T, Ota H. Impact of obesity on incident hypertension independent of weight gain among non-hypertensive Japanese: The Ibaraki Prefectural Health Study (IPHS). J Hypertens 2012; 30:1122-1128. Cui R, Iso H, Yamagishi K, Saito I, Kokubo Y, Inoue M, Tsugane S; for the JPHC Study Group. High serum total cholesterol levels is a risk factor for ischemic stroke for general Japanese: the JPHC Study. Atherosclerosis 2012; 221:565-569 Maruyama M, Ohira T, Imano H, Kitamura A, Kiyama M, Okada T, Maeda K, Yamagishi K, Noda H, Ishikawa Y, Shimamoto T, Iso H. Trends in sudden cardiac death and its risk factors in Japan from 1981 to 2005: The Circulatory Risk in Communities Study (CIRCS). BMJ Open 2012; 2:e00573. 和文原著 山岸良匡,大久保一郎,佐藤眞一,北村明彦,木山昌彦,岡田武夫,谷川武,大平哲也,今野弘規,近藤正英,石川善紀,嶋本喬,磯博康.長期的な脳卒中予防対策に関する費用効果分析:自治体の視点から見た分析.日循予防誌 2012; 47:223-229. 村越伸行,常岡秀和,山岸良匡,横山泰廣,許東洙,五十嵐都,山崎浩,井藤葉子,北村明彦,岡田武夫,大平哲也,谷川武,関口幸夫,夛田浩,高木雅彦,磯博康,青沼和隆;Brugada症候群の長期予後調査研究班.一般住民検診におけるBrugada型心電図の長期予後調査.心電図 2012; 32 Suppl-1:107-111. 和文総説 大平哲也,今野弘規,山岸良匡,木山昌彦,北村明彦,磯博康.健診による健康増進のエビデンス(特定健診以前).月刊糖尿病 2012; 4:77-82. 北村明彦,野田博之,木山昌彦,岡田武夫,中村正和,小野優,梶浦貢,石川善紀,山岸良匡,磯博康,ほかCIRCS研究者グループ.特定健診データをもとに脳・心血管疾患発症を予測するツールの開発.THERAPEUTIC RESEARCH 2012; 33:1541-1545. 山岸良匡,磯博康.健康増進計画の評価と「その次」 次期計画に向けて何を重視すべきか:循環器疾患予防対策 「減塩」を中心とした脳卒中半減対策事業の成果から.保健師ジャーナル 2012; 68:486-489. 英文著書 Imano H, Kitamura A, Kiyama M, Ohira T, Cui R, Muraki I, Shimizu Y, Umesawa M, Maeda K, Ido M, Okada T, Nakamura M, Noda H, Yamagishi K, Sato S, Tanigawa T, Ishikawa Y, Iso H. Usefulness of skinfold thickness measurements for determining body fat distribution and disease risk for Japanese men and women. In: Preedy VR, editor. Handbook of Anthropometry: Physical Measures of Human Form in Health and Disease. New York: Springer, 2012 p.2667-2678.